KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Assets Average (2019 - 2025)

Historic Assets Average for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to $1.1 billion.

  • Vir Biotechnology's Assets Average fell 3017.53% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 3017.53%. This contributed to the annual value of $1.7 billion for FY2024, which is 2972.32% down from last year.
  • According to the latest figures from Q3 2025, Vir Biotechnology's Assets Average is $1.1 billion, which was down 3017.53% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's Assets Average peaked at $2.8 billion during Q2 2022, and registered a low of $1.0 billion during Q1 2021.
  • For the 5-year period, Vir Biotechnology's Assets Average averaged around $1.8 billion, with its median value being $1.7 billion (2024).
  • Its Assets Average has fluctuated over the past 5 years, first soared by 15105.83% in 2022, then tumbled by 3209.56% in 2024.
  • Vir Biotechnology's Assets Average (Quarter) stood at $1.6 billion in 2021, then soared by 73.74% to $2.7 billion in 2022, then decreased by 27.9% to $2.0 billion in 2023, then fell by 26.91% to $1.4 billion in 2024, then decreased by 23.65% to $1.1 billion in 2025.
  • Its Assets Average was $1.1 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.4 billion in Q1 2025.